Cannabis use in pregnancy linked to a greater risk of autism

Is MMJ value as a therapy for multiple sclerosis? A Doctors Point of View! Do you agree?

In the largest study of its kind, researchers from The Ottawa Hospital, BORN Ontario and the University of Ottawa found that children whose mothers reported using cannabis during pregnancy were at greater risk of autism. The incidence of autism was 4 per 1000 person-years among children exposed to cannabis in pregnancy, compared to 2.42 among unexposed children. The findings were published in the prestigious medical journal Nature Medicine.

Recreational cannabis is now legal in Canada, but that doesn’t mean it’s safe for people who are pregnant or breastfeeding. Health Canada and the Society of Obstetricians and Gynaecologists of Canada recommend against these populations using cannabis, and health warnings to this effect appear on cannabis packaging.

“Despite these warnings, there is evidence that more people are using cannabis during pregnancy,” said Dr. Mark Walker, Chief of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital, professor at the University of Ottawa and senior author on the study.  “This is concerning, because we know so little about how cannabis affects pregnant women and their babies. Parents-to-be should inform themselves of the possible risks, and we hope studies like ours can help.”

The research team reviewed data from every birth in Ontario between 2007 and 2012, before recreational cannabis was legalized. Of the half a million women in the study, about 3,000 (0.6 percent) reported using cannabis during pregnancy.

The researchers had previously found that cannabis use in pregnancy was linked to an increased risk of preterm birth, and created an animated video to summarize their findings. In that study, they found that women who used cannabis during pregnancy often used other substances including tobacco, alcohol and opioids.

Considering those findings, in the current study the researchers specifically looked at 2,200 women who reported using only cannabis during pregnancy, and no other substances. They found that babies born to this group still had an increased risk of autism compared to those who did not use cannabis.

“In the past, we haven’t had good data on the effect of cannabis on pregnancies. This is one of the largest studies on this topic to date.”- Dr. Daniel CorsiThe researchers do not know how much cannabis the women were using, how often, at what time during their pregnancy, or how it was consumed. They also note that while they tried to control for other factors that could influence neurological development, their study can still only show association – not cause and effect.

As cannabis becomes more socially acceptable, health-care researchers are mindful that some parents-to-be might think it can be used to treat morning sickness.

“In the past, we haven’t had good data on the effect of cannabis on pregnancies,” said Dr. Daniel Corsi, Epidemiologist at The Ottawa Hospital and BORN Ontario, which is affiliated with the CHEO Research Institute. “This is one of the largest studies on this topic to date. We hope our findings will help women and their health-care providers make informed decisions.”

Women who are thinking about or currently using cannabis during pregnancy should talk to their health-care provider to help make an informed choice about what is best for them and their baby.

Reference: Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Daniel Corsi, Jessy Donelle, Ewa Sucha, Steven Hawken, Helen Hsu, Darine El-Chaâr, Lise Bisnaire, Deshayne Fell, Shi Wu Wen, Mark Walker. Nature Medicine. Aug 10, 2020. DOI: 10.1038/s41591-020-1002-5

Core Resources: BORN OntarioICESCanadian Institute for Health Information

Funders: This study was funded by the Canadian Institutes of Health Research. Research at The Ottawa Hospital is possible thanks to generous donations to The Ottawa Hospital Foundation. BORN Ontario is supported by the Ontario Ministry of Health and Long Term Care.

Legal Cannabis hemp oil effectively treats chronic neuropathic pain

UNM researchers have found that hemp oil helps to reduce pain in mice. CREDIT UNM

Researchers examine the effectiveness of consuming hemp oil extracted from the whole Cannabis plant using a chronic neuropathic pain animal model. Researchers at The University of New Mexico (UNM) showed that legal Cannabis hemp oil reduced mechanical pain sensitivity 10-fold for several hours in mice with chronic post-operative neuropathic pain.

Distinguished from its still largely criminally prohibited cousin, “hemp” refers to Cannabis plants with less than 0.3 percent tetrahydrocannabinol (THC) per mass. Hemp is now federally legal to produce and consume in most regions throughout the United States (U.S) as a result of the Hemp Farming Act, proposed by the U.S. Congress and signed into law by President Donald Trump in 2018.

This major breakthrough in cannabis prohibition now enables millions of Americans the ability to access a natural, effective, and relatively safe alternative option for treating chronic pain. Conventional pharmacological drugs, namely opioids, are driving the leading form of preventable deaths and conventional medical errors are the third leading cause of death in the U.S.

The University of New Mexico has conducted a series of recent studies testing the effectiveness and safety of consuming the Cannabis plant, but this is the first study measuring the therapeutic potential of legal hemp oil with low THC levels.

“Cannabis plants with low THC are still psychoactive, but tend to result in less psychedelic experiences, while still offering profound and often immediate relief from symptoms such as pain, anxiety, and depression,” says co-researcher, Dr. Jacob Miguel Vigil, associate professor in the UNM Psychology Department.

Using a chronic neuropathic pain model that exposes mice to post-operative neuropathic pain equivalent to several years of chronic pain in human clinical patients, the researchers were able to examine how hemp oil influences momentary pain sensitivity to the affected region. For several hours after Cannabis consumption the mice demonstrated effective pain relief, approaching the mechanical pain sensitivity of naïve control mice that did not undergo the surgical operation.

“Our lab utilizes a unique nerve injury model mimicking human neuropathic pain that has allowed demonstration of hemp’s reversal of the pain related behavior” said one of the lead investigators, Dr. Karin N. Westlund, Department of Anesthesiology, their article titled “The Therapeutic Effectiveness of Full Spectrum Hemp Oil Using a Chronic Neuropathic Pain Model,” published in the journal Life.

Studies in animals can be superior to clinical trials because they circumvent human biases and expectancy effects, or perceptual and cognitive reactions to enrollment in cannabis-themed experiments. Several studies measuring the effects of cannabis in humans observe patients reporting psychedelic experiences, whether or not they received the active cannabis agent, otherwise referred to as the ‘placebo effect.’

The study examined the effectiveness of “LyFeBaak” hemp oil, produced by Organic-Energetic Solutions, which has been available for legal purchase in New Mexico since 2019. “We grow hemp that is optimized to potentiate the plants utmost health and vitality through hypermineralization techniques, rather than merely plants that are grown in a state of fight-or-flight, which unfortunately is common in the cannabis industry. These techniques have enabled us to produce hemp products that patients swear are effective for treating dozens of mental and physical health conditions. The new changes in hemp laws are now allowing us to test these claims,” adds co-author and hemp grower, Anthony L. Ortiz.

“Hemp plants contain numerous therapeutic constituents that likely contribute to analgesic responses, including terpenes and flavonoids, which in theory, work together like members of a symphony, often described as the entourage effect,” says fellow researcher, Jegason P. Diviant. Several clinical investigations have shown that medications based on synthetic cannabis analogues and isolated compounds tend to offer lower reported symptom relief and a greater number of negative side effects as compared to whole plant, or “full-spectrum” Cannabis flower and plant-based extracts.

The authors do caution that few studies exist on the long-term use of hemp oil, due mostly to historical federal prohibition laws in the U.S. “However, this is an extremely exciting time in modern medical discovery, because the average citizen now has legal access to a completely natural and effective medication that can be easily and cheaply produced, simply by sticking a seed in the ground and caring for it as you would any other important part of your life,” says Vigil.

Bill introduced for people with autism to have access to medical marijuana for treatment




MMJ and Autism

MMJ and Autism




Assemblyman Angelo Santabarbara introduced legislation to add autism spectrum disorder to the list of conditions for which medical marijuana can be prescribed for treatment.

The latest report from the Center for Disease Control shows that 1-in-59 children in the United States are diagnosed with an autism spectrum disorder – up from 1-in-68 back in 2012.

Assemblyman Santabarbara said recent research has shown that the Cannabis plant extract, CBD oil, can be effective therapy for children with certain cases of autism as far as improving behavior, anxiety levels and their ability to communicate.




“What we are talking about is the CDC part of the plant extract that has been shown to treat a number of symptoms that are also common with those that have autism – anxiety, behavioral conditions, communication difficulties” said Assemblyman Santabarbara